USC
USC Team Counts Circulating Tumor Cells to Predict Treatment Response, Survival in Prostate Cancer
Premium
The researchers used the CellSearch assay to measure circulating tumor cells and determine the response to certain treatments as well as survival outcomes.
The assay distinguishes high-grade serous ovarian cancer tumors from benign masses using cell-free DNA methylation.
Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research
Epic will access the center's liquid biopsy samples and expand its platform to in-depth characterization of cell-free fractions and circulating tumor cells.
To detect clinically relevant levels, the magneto-optic system measured magnetic nanocrystals in rabbit blood created by the malaria parasite.